IFI30 and neoplasm: Since the majority of MHC class II expression in RNAseq data from melanoma samples is derived from APCs [48] and tumor-infiltrating APCs are generally GILT and MHC class II positive (current study and [31]), there is a need to assess GILT and other MHC class II pathway components in specific cell types, such as tumor cells, as performed in the current study.